As the world waits for vaccines against COVID-19, testing wastewater can give communities and smaller locales, such as school districts, valuable signals about infections trends.
Currently there is no specific antiviral drug to treat COVID-19 and no vaccine to prevent it. Most treatment strategies focus on symptomatic management and supportive therapy.
It is essential to add genomic data from all global populations - including Africa. This will ensure that everyone can benefit from the advances in health.
Hospitals are losing staff to quarantines as rural COVID-19 cases rise, and administrators fear flu season will make it worse. And then there’s the politics.
Jason Farley, Johns Hopkins University School of Nursing
More states are adding mask mandates as COVID-19 cases soar. If you’re traveling, shopping or seeing friends and family in person, masks are a crucial protective measure.
The continued entrapment of African countries in the global circuit of capital and its proclivity to large scale accumulation imperils the ability of many to cope with the pandemic.
A stroke often leads to the sudden onset of weakness involving the face, arm or leg, an inability to speak, difficulty walking or impaired vision. Strokes can cause death and irreversible disability.
One of the main challenges remains that diagnostics and drugs for people suffering from advanced HIV aren’t readily available. This group of people is vulnerable to deadly opportunistic infections.
Biden will begin his presidency in the midst of a global public health crisis that’s already killed over 240,000 people in the US alone. His team is already planning how to get COVID-19 under control.
The rapid rise in diabetes mustn’t be overlooked, as it could have devastating health and economic effects. Most national health systems are already struggling with infectious diseases.
Being physically active is largely not an individual choice, but a result of what funds, spaces, places and opportunities are available to the individual and communities.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand